Activity of propyl-propane-thiosulfinate and propyl-propane-thiosulfonate against carbapenem-resistant Gram-negative bacteria
- PMID: 38757239
- DOI: 10.1111/apm.13420
Activity of propyl-propane-thiosulfinate and propyl-propane-thiosulfonate against carbapenem-resistant Gram-negative bacteria
Abstract
Organosulfur compounds derived from plants of the Allium genus, such as propyl-propane-thiosulfinate (PTS) and propyl-propane-thiosulfonate (PTSO), have been proposed as an alternative in antibiotic resistance. The aim of this study was to compare the activity of these substances with other antibiotics against clinical isolates of carbapenem-resistant (CAR-R) and carbapenem-susceptible (CAR-S) Gram-negative bacteria. A total of 126 clinical isolates of CAR-R and 155 CAR-S bacteria were selected, including Enterobacterales, A. baumannii and P. aeruginosa. The antibiotic susceptibility of all isolates was assessed using the microdilution and Kirby-Bauer methods for PTS, PTSO, amoxicillin/clavulanate, piperacillin/tazobactam, cefotaxime, ceftazidime, cefepime, imipenem, ciprofloxacin, and amikacin. Both PTS and PTSO demonstrated in vitro bactericidal activity against CAR-R Enterobacteriaceae and A. baumannii, with no significant difference in activity compared to their response against CAR-S isolates. However, both compounds were less active against P. aeruginosa than against any of the other bacteria, regardless of their resistance to carbapenems. In all cases, the minimum inhibitory concentration values of PTSO were significantly lower than those of PTS. These findings offer valuable information about the potential antibacterial use of these substances, particularly against infections that currently have limited therapeutic options.
Keywords: Gram‐negative bacilli; antibacterial activity; carbapenemases; propyl‐propane‐thiosulfinate; propyl‐propane‐thiosulfonate.
© 2024 The Authors. APMIS published by John Wiley & Sons Ltd on behalf of Scandinavian Societies for Pathology, Medical Microbiology and Immunology.
Similar articles
-
In Vitro Antibacterial Activity of Propyl-Propane-Thiosulfinate and Propyl-Propane-Thiosulfonate Derived from Allium spp. against Gram-Negative and Gram-Positive Multidrug-Resistant Bacteria Isolated from Human Samples.Biomed Res Int. 2018 Sep 17;2018:7861207. doi: 10.1155/2018/7861207. eCollection 2018. Biomed Res Int. 2018. PMID: 30310819 Free PMC article.
-
Antibacterial and Antifungal Activity of Propyl-Propane-Thiosulfinate and Propyl-Propane-Thiosulfonate, Two Organosulfur Compounds from Allium cepa: In Vitro Antimicrobial Effect via the Gas Phase.Pharmaceuticals (Basel). 2020 Dec 29;14(1):21. doi: 10.3390/ph14010021. Pharmaceuticals (Basel). 2020. PMID: 33383767 Free PMC article.
-
Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.J Antimicrob Chemother. 2005 Nov;56(5):893-8. doi: 10.1093/jac/dki335. Epub 2005 Sep 14. J Antimicrob Chemother. 2005. PMID: 16162664
-
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.
-
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.Int J Antimicrob Agents. 2021 May;57(5):106344. doi: 10.1016/j.ijantimicag.2021.106344. Epub 2021 Apr 20. Int J Antimicrob Agents. 2021. PMID: 33857539
References
REFERENCES
-
- Mousavi SM, Babakhani S, Moradi L, Karami S, Shahbandeh M, Mirshekar M, et al. Bacteriophage as a novel therapeutic weapon for killing colistin‐resistant multi‐drug‐resistant and extensively drug‐resistant gram‐negative bacteria. Curr Microbiol. 2021;78:4023–4036.
-
- Meng H, Han L, Niu M, Xu L, Xu M, An Q, et al. Risk factors for mortality and outcomes in hematological malignancy patients with carbapenem‐resistant Klebsiella pneumoniae bloodstream infections. Infect Drug Resist. 2022;15:4241–4251.
-
- Montrucchio G, Costamagna A, Pierani T, Petitti A, Sales G, Pivetta E, et al. Bloodstream infections caused by carbapenem‐resistant pathogens in intensive care units: risk factors analysis and proposal of a prognostic score. Pathogens. 2022;11:718.
-
- Sánchez‐García JM, Sorlózano‐Puerto A, Navarro‐Marí JM, Gutiérrez Fernández J. Evolution of the antibiotic‐resistance of microorganisms causing urinary tract infections: a 4‐year epidemiological surveillance study in a hospital population. Rev Clin Esp (Barc). 2019;219:116–123.
-
- Garnacho‐Montero J, Amaya‐Villar R. The problem of multi‐resistance in gram‐negative bacilli in intensive care units: treatment and prevention strategies. Med Intensiva. 2022;46:326–335.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
